Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency.

[1]  N. Gregersen,et al.  Fluxomic evidence for impaired contribution of short-chain acyl-CoA dehydrogenase to mitochondrial palmitate β-oxidation in symptomatic patients with ACADS gene susceptibility variants. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[2]  A. Laquérriere,et al.  Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease. , 2016, Revue neurologique.

[3]  Y. Hamel,et al.  Acute rhabdomyolysis and inflammation , 2015, Journal of Inherited Metabolic Disease.

[4]  C. Indiveri,et al.  Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane , 2014, Molecular and cellular biochemistry.

[5]  P. Sachs,et al.  Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data , 2014, Journal of Inherited Metabolic Disease.

[6]  A. Smahi,et al.  Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblasts. , 2013, Biochimica et biophysica acta.

[7]  J. Jans,et al.  Differences between acylcarnitine profiles in plasma and bloodspots. , 2013, Molecular genetics and metabolism.

[8]  K. Al-Thihli,et al.  Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β-oxidation disorders in adult patients with rhabdomyolysis , 2014, Journal of Inherited Metabolic Disease.

[9]  P. Sachs,et al.  Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients , 2013, Journal of Inherited Metabolic Disease.

[10]  G. Briand,et al.  A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency. , 2012, JIMD reports.

[11]  C. Angelini,et al.  Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency , 2011, Neurological research.

[12]  P. Laforêt,et al.  Disorders of muscle lipid metabolism: Diagnostic and therapeutic challenges , 2010, Neuromuscular Disorders.

[13]  B. Andresen,et al.  A novel mutation of the ACADM gene (c.145C>G) associated with the common c.985A>G mutation on the other ACADM allele causes mild MCAD deficiency: a case report , 2010, Orphanet journal of rare diseases.

[14]  R. Wanders,et al.  A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation , 2010, Journal of Inherited Metabolic Disease.

[15]  G. Briand,et al.  Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[16]  W. Rizzo,et al.  Mitochondrial fatty-acid oxidation disorders. , 2008, Seminars in pediatric neurology.

[17]  W. Wuyts,et al.  Recurrent post-infectious rhabdomyolysis in muscle CPT-II deficiency caused by a novel missense mutation. , 2008, Acta neurologica Belgica.

[18]  A. Munnich,et al.  Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. , 2004, Molecular aspects of medicine.

[19]  P. Divry,et al.  Diagnosis of inborn errors of metabolism by acylcarnitine profiling in blood using tandem mass spectrometry , 1997, Journal of Inherited Metabolic Disease.

[20]  P. Divry,et al.  Metabolic studies in a patient with severe carnitine palmitoyltransferase type II deficiency. , 1998, Clinica chimica acta; international journal of clinical chemistry.

[21]  A. Legrand,et al.  Rapid Diagnosis of Long Chain and Medium Chain Fatty Acid Oxidation Disorders Using Lymphocytes , 1995, Annals of clinical biochemistry.

[22]  J. Saudubray,et al.  Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. , 1991, The Journal of clinical investigation.

[23]  M. Rocchi,et al.  cDNA cloning, sequence analysis, and chromosomal localization of the gene for human carnitine palmitoyltransferase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. S. Murthy,et al.  Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Dimauro,et al.  Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria , 1973, Science.